Health Benefits of Using Chemiluminescence CLIA Kits for Autoimmune Disease Testing Posted on July 20, 2026 By Michael Wilson Autoimmune diseases are notoriously difficult to diagnose and monitor because they often involve subtle biomarker changes, overlapping symptoms, and the need for highly sensitive detection of specific autoantibodies. Researchers studying conditions like lupus, rheumatoid arthritis, and autoimmune thyroiditis need assay technologies capable of detecting these biomarkers accurately, even at very… Read more